The Southern University medical cannabis program is one step closer to becoming an operational reality. On July 19, 2017, Southern University announced that it had received seven medical cannabis cultivator applications.
The applicants are as follows:
- Advanced Bio Medical of Lafayette;
- AquaPharm of New Orleans;
- Citiva Louisiana of Mandeville;
- Columbia Care of New Roads, but from New York;
- Med Louisiana of Lafayette;
- Southern Roots of Baton Rouge; and
- United States Hemp Corporation of Baton Rouge, but from Nevada.(USHC)
According to The Advocate, Citiva Louisiana, Columbia Care and Southern Roots also bid on Louisiana State University’s medical cannabis cultivation contract, but were unsuccessful. LSU’s contract was awarded to GB Sciences (OTCQB:GBLX).
Southern University held a pre-proposal conference for potential medical cannabis cultivation applicants on May 19, with attendees including two representatives from Advanced Bio Medical, six representatives from AquaPharm, one representative from Citiva Louisiana, two representatives from Med Louisiana, two representatives from Southern Roots and two representatives from United States Hemp Corporation, including Dr. Derrick Brooks, a board member of Dewmar International BMC (OTC Pink:DEWM), among others.
According to The Advocate, Southern Roots has approximately 100 investors and Citiva Louisiana’s investors include local businessman John Barry, physicians, pharmacists and a venture capitalist.
Southern University is currently reviewing the seven applications and plans to submit its completed review to the SU Agricultural Center’s evaluation committee by July 31.
The winner of the cultivation contract will have to invest $5-7 million in the Southern University medical cannabis operation and use a seed-to-sale tracking system.